ARDENT HEALTH INC (ARDT) Fundamental Analysis & Valuation

NYSE:ARDT • US03980N1072

Current stock price

9.27 USD
-0.13 (-1.38%)
At close:
9.27 USD
0 (0%)
After Hours:

This ARDT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. ARDT Profitability Analysis

1.1 Basic Checks

  • In the past year ARDT was profitable.
  • In the past year ARDT had a positive cash flow from operations.
  • In the past 5 years ARDT has always been profitable.
  • Of the past 5 years ARDT 4 years had a positive operating cash flow.
ARDT Yearly Net Income VS EBIT VS OCF VS FCFARDT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2025 0 200M 400M

1.2 Ratios

  • ARDT has a Return On Assets (2.57%) which is in line with its industry peers.
  • ARDT has a Return On Equity of 10.55%. This is in the better half of the industry: ARDT outperforms 72.00% of its industry peers.
  • ARDT has a better Return On Invested Capital (6.25%) than 64.00% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for ARDT is below the industry average of 8.51%.
Industry RankSector Rank
ROA 2.57%
ROE 10.55%
ROIC 6.25%
ROA(3y)2.65%
ROA(5y)N/A
ROE(3y)12.39%
ROE(5y)N/A
ROIC(3y)6.4%
ROIC(5y)N/A
ARDT Yearly ROA, ROE, ROICARDT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • The Profit Margin of ARDT (2.15%) is better than 61.00% of its industry peers.
  • In the last couple of years the Profit Margin of ARDT has declined.
  • ARDT has a Operating Margin of 5.15%. This is in the better half of the industry: ARDT outperforms 62.00% of its industry peers.
  • In the last couple of years the Operating Margin of ARDT has grown nicely.
  • ARDT's Gross Margin of 57.98% is amongst the best of the industry. ARDT outperforms 82.00% of its industry peers.
  • In the last couple of years the Gross Margin of ARDT has grown nicely.
Industry RankSector Rank
OM 5.15%
PM (TTM) 2.15%
GM 57.98%
OM growth 3Y9.66%
OM growth 5YN/A
PM growth 3Y-16.46%
PM growth 5YN/A
GM growth 3Y3.05%
GM growth 5YN/A
ARDT Yearly Profit, Operating, Gross MarginsARDT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2025 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. ARDT Health Analysis

2.1 Basic Checks

  • ARDT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for ARDT remains at a similar level compared to 1 year ago.
  • Compared to 1 year ago, ARDT has an improved debt to assets ratio.
ARDT Yearly Shares OutstandingARDT Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 50M 100M
ARDT Yearly Total Debt VS Total AssetsARDT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.2 Solvency

  • An Altman-Z score of 1.96 indicates that ARDT is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • ARDT's Altman-Z score of 1.96 is in line compared to the rest of the industry. ARDT outperforms 52.00% of its industry peers.
  • ARDT has a debt to FCF ratio of 4.25. This is a neutral value as ARDT would need 4.25 years to pay back of all of its debts.
  • ARDT has a better Debt to FCF ratio (4.25) than 63.00% of its industry peers.
  • A Debt/Equity ratio of 0.84 indicates that ARDT is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.84, ARDT is in line with its industry, outperforming 45.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF 4.25
Altman-Z 1.96
ROIC/WACC0.72
WACC8.63%
ARDT Yearly LT Debt VS Equity VS FCFARDT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 0 500M 1B

2.3 Liquidity

  • A Current Ratio of 1.97 indicates that ARDT should not have too much problems paying its short term obligations.
  • ARDT has a better Current ratio (1.97) than 79.00% of its industry peers.
  • A Quick Ratio of 1.85 indicates that ARDT should not have too much problems paying its short term obligations.
  • The Quick ratio of ARDT (1.85) is better than 78.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.97
Quick Ratio 1.85
ARDT Yearly Current Assets VS Current LiabilitesARDT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 500M 1B 1.5B 2B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. ARDT Growth Analysis

3.1 Past

  • The earnings per share for ARDT have decreased strongly by -35.89% in the last year.
  • Measured over the past years, ARDT shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -10.52% on average per year.
  • Looking at the last year, ARDT shows a small growth in Revenue. The Revenue has grown by 6.01% in the last year.
  • ARDT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.23% yearly.
EPS 1Y (TTM)-35.89%
EPS 3Y-10.52%
EPS 5YN/A
EPS Q2Q%-60.49%
Revenue 1Y (TTM)6.01%
Revenue growth 3Y7.23%
Revenue growth 5YN/A
Sales Q2Q%-0.08%

3.2 Future

  • ARDT is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -5.81% yearly.
  • ARDT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.23% yearly.
EPS Next Y-31.51%
EPS Next 2Y-13.49%
EPS Next 3Y-5.81%
EPS Next 5YN/A
Revenue Next Year3.4%
Revenue Next 2Y3.96%
Revenue Next 3Y4.23%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ARDT Yearly Revenue VS EstimatesARDT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B
ARDT Yearly EPS VS EstimatesARDT Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

8

4. ARDT Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 5.62, the valuation of ARDT can be described as very cheap.
  • ARDT's Price/Earnings ratio is rather cheap when compared to the industry. ARDT is cheaper than 98.00% of the companies in the same industry.
  • ARDT's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.18.
  • The Price/Forward Earnings ratio is 8.20, which indicates a very decent valuation of ARDT.
  • Based on the Price/Forward Earnings ratio, ARDT is valued cheaply inside the industry as 95.00% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of ARDT to the average of the S&P500 Index (37.96), we can say ARDT is valued rather cheaply.
Industry RankSector Rank
PE 5.62
Fwd PE 8.2
ARDT Price Earnings VS Forward Price EarningsARDT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ARDT is valued cheaply inside the industry as 97.00% of the companies are valued more expensively.
  • 94.00% of the companies in the same industry are more expensive than ARDT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 5.12
EV/EBITDA 3.56
ARDT Per share dataARDT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • ARDT has a very decent profitability rating, which may justify a higher PE ratio.
  • A cheap valuation may be justified as ARDT's earnings are expected to decrease with -5.81% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-13.49%
EPS Next 3Y-5.81%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ARDT Dividend Analysis

5.1 Amount

  • ARDT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ARDT Fundamentals: All Metrics, Ratios and Statistics

ARDENT HEALTH INC

NYSE:ARDT (4/13/2026, 8:04:00 PM)

After market: 9.27 0 (0%)

9.27

-0.13 (-1.38%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)03-04
Earnings (Next)05-04
Inst Owners74.89%
Inst Owner Change0%
Ins Owners2.42%
Ins Owner Change2.08%
Market Cap1.32B
Revenue(TTM)6.32B
Net Income(TTM)135.81M
Analysts77.89
Price Target13.15 (41.86%)
Short Float %2.54%
Short Ratio6.76
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)8.32%
Min EPS beat(2)-8.22%
Max EPS beat(2)24.85%
EPS beat(4)3
Avg EPS beat(4)32.72%
Min EPS beat(4)-8.22%
Max EPS beat(4)71.2%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.81%
Min Revenue beat(2)-3.54%
Max Revenue beat(2)-0.08%
Revenue beat(4)1
Avg Revenue beat(4)-0.33%
Min Revenue beat(4)-3.54%
Max Revenue beat(4)4.33%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.97%
PT rev (3m)-6.81%
EPS NQ rev (1m)-0.49%
EPS NQ rev (3m)-24.44%
EPS NY rev (1m)-17.54%
EPS NY rev (3m)-20.66%
Revenue NQ rev (1m)0.06%
Revenue NQ rev (3m)-0.74%
Revenue NY rev (1m)-1.28%
Revenue NY rev (3m)-1.33%
Valuation
Industry RankSector Rank
PE 5.62
Fwd PE 8.2
P/S 0.21
P/FCF 5.12
P/OCF 2.82
P/B 1.03
P/tB 4.15
EV/EBITDA 3.56
EPS(TTM)1.65
EY17.8%
EPS(NY)1.13
Fwd EY12.19%
FCF(TTM)1.81
FCFY19.52%
OCF(TTM)3.29
OCFY35.52%
SpS44.26
BVpS9.01
TBVpS2.23
PEG (NY)N/A
PEG (5Y)N/A
Graham Number18.29
Profitability
Industry RankSector Rank
ROA 2.57%
ROE 10.55%
ROCE 7.67%
ROIC 6.25%
ROICexc 7.5%
ROICexgc 10.34%
OM 5.15%
PM (TTM) 2.15%
GM 57.98%
FCFM 4.09%
ROA(3y)2.65%
ROA(5y)N/A
ROE(3y)12.39%
ROE(5y)N/A
ROIC(3y)6.4%
ROIC(5y)N/A
ROICexc(3y)7.47%
ROICexc(5y)N/A
ROICexgc(3y)10.27%
ROICexgc(5y)N/A
ROCE(3y)7.85%
ROCE(5y)N/A
ROICexgc growth 3Y13.26%
ROICexgc growth 5YN/A
ROICexc growth 3Y13.93%
ROICexc growth 5YN/A
OM growth 3Y9.66%
OM growth 5YN/A
PM growth 3Y-16.46%
PM growth 5YN/A
GM growth 3Y3.05%
GM growth 5YN/A
F-Score6
Asset Turnover1.2
Health
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF 4.25
Debt/EBITDA 2.24
Cap/Depr 136.1%
Cap/Sales 3.35%
Interest Coverage 4.95
Cash Conversion 97.76%
Profit Quality 190.42%
Current Ratio 1.97
Quick Ratio 1.85
Altman-Z 1.96
F-Score6
WACC8.63%
ROIC/WACC0.72
Cap/Depr(3y)120.61%
Cap/Depr(5y)114.5%
Cap/Sales(3y)3.01%
Cap/Sales(5y)2.97%
Profit Quality(3y)135.8%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-35.89%
EPS 3Y-10.52%
EPS 5YN/A
EPS Q2Q%-60.49%
EPS Next Y-31.51%
EPS Next 2Y-13.49%
EPS Next 3Y-5.81%
EPS Next 5YN/A
Revenue 1Y (TTM)6.01%
Revenue growth 3Y7.23%
Revenue growth 5YN/A
Sales Q2Q%-0.08%
Revenue Next Year3.4%
Revenue Next 2Y3.96%
Revenue Next 3Y4.23%
Revenue Next 5YN/A
EBIT growth 1Y-19.76%
EBIT growth 3Y17.59%
EBIT growth 5YN/A
EBIT Next Year58%
EBIT Next 3Y20.72%
EBIT Next 5YN/A
FCF growth 1Y102.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y49.36%
OCF growth 3YN/A
OCF growth 5YN/A

ARDENT HEALTH INC / ARDT Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ARDENT HEALTH INC?

ChartMill assigns a fundamental rating of 5 / 10 to ARDT.


Can you provide the valuation status for ARDENT HEALTH INC?

ChartMill assigns a valuation rating of 8 / 10 to ARDENT HEALTH INC (ARDT). This can be considered as Undervalued.


What is the profitability of ARDT stock?

ARDENT HEALTH INC (ARDT) has a profitability rating of 6 / 10.


How financially healthy is ARDENT HEALTH INC?

The financial health rating of ARDENT HEALTH INC (ARDT) is 5 / 10.


What is the earnings growth outlook for ARDENT HEALTH INC?

The Earnings per Share (EPS) of ARDENT HEALTH INC (ARDT) is expected to decline by -31.51% in the next year.